BeiGene Ltd. (BGNE)
NASDAQ: BGNE
· Real-Time Price · USD
184.71
0.90 (0.49%)
At close: Dec 31, 2024, 9:00 PM
BeiGene Revenue Breakdown
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Other Revenue | 4.73M | n/a | 59.05M | 41.52M | 37.51M | 38.12M | 37.06M | 45.05M | 26.18M | 13.98M | 11.37M | 15.11M | n/a | n/a | n/a | n/a | n/a | 150M | 20.41M | 40.32M | 15.76M | 3.2M | 1.74M |
| Collaboration Other Revenue Growth | n/a | -100.00% | +42.24% | +10.68% | -1.61% | +2.86% | -17.74% | +72.09% | +87.28% | +22.97% | -24.76% | n/a | n/a | n/a | n/a | n/a | -100.00% | +634.86% | -49.37% | +155.89% | +391.88% | +84.19% | n/a |
| Collaboration Research And Development Service Revenue | n/a | 20.38M | 51.98M | n/a | n/a | n/a | n/a | n/a | n/a | 13.98M | 11.37M | 499.75M | n/a | n/a | n/a | n/a | n/a | 25.74M | n/a | 9.73M | n/a | 21.38M | 9.29M |
| Collaboration Research And Development Service Revenue Growth | -100.00% | -60.79% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +22.97% | -97.73% | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | +130.02% | n/a |
| Collaboration Revenue | 4.73M | 189.9M | 213.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 185.2M | n/a | n/a | n/a | n/a | n/a |
| Collaboration Revenue Growth | -97.51% | -11.03% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Right To Access Intellectual Property Revenue Revenue | n/a | 52.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Right To Access Intellectual Property Revenue Revenue Growth | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|
| All Other Countries Except China And United States Of America Revenue | 28.98M | 73.26M | 163.84M | n/a | 71.97M | 23.04M | 75.54M |
| All Other Countries Except China And United States Of America Revenue Growth | -60.44% | -55.29% | n/a | -100.00% | +212.33% | -69.50% | n/a |
| China Revenue | 1.1B | 840.03M | 517.17M | 290.65M | 134.69M | 42.79M | n/a |
| China Revenue Growth | +31.18% | +62.43% | +77.94% | +115.79% | +214.75% | n/a | n/a |
| Europe Revenue | 202.01M | n/a | n/a | 18.23M | n/a | n/a | n/a |
| Europe Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 1.13B | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 455.22M | 443.73M | 427.43M | 416.55M | 364.42M | 395.03M | 328.5M | 328.98M | 322.89M | 331.4M | 294.57M | 306.5M | 269.23M | 232.29M | 182.11M | 208.21M | 160.84M | 124.05M | 107.08M | 143.35M | 105M | 82.25M | 57.65M | 72.49M | 48.82M | 45.16M | 28.91M | 27.41M | 15.64M | 10.78M | 8.77M | 8.34M | 4.72M | 3.9M | 3.13M | 2.95M | 2.02M | 1.21M | 1.13M |
| Selling, General, and Administrative Revenue Growth | +2.59% | +3.81% | +2.61% | +14.30% | -7.75% | +20.25% | -0.15% | +1.89% | -2.57% | +12.50% | -3.89% | +13.84% | +15.90% | +27.56% | -12.54% | +29.45% | +29.66% | +15.85% | -25.30% | +36.53% | +27.67% | +42.68% | -20.48% | +48.48% | +8.10% | +56.18% | +5.47% | +75.28% | +45.13% | +22.90% | +5.18% | +76.56% | +20.95% | +24.57% | +6.24% | +45.97% | +67.30% | +6.71% | n/a |
| Research and Development Revenue | 496.18M | 454.47M | 460.64M | 473.13M | 453.26M | 422.76M | 408.58M | 1.26B | 426.36M | 378.21M | 389.92M | 1.46B | 351.94M | 356.09M | 320.73M | 1.29M | 349.07M | 285.97M | 304.3M | -927.34M | 236.97M | 228.76M | 178.35M | -679M | 147.59M | 164.25M | 109.7M | -269.02M | 87.66M | 47.24M | 42.77M | 98.03M | 30.11M | 21.12M | 17.88M | 58.25B | 13.35M | 6.74M | 10.06M |
| Research and Development Revenue Growth | +9.18% | -1.34% | -2.64% | +4.38% | +7.21% | +3.47% | -67.63% | +196.06% | +12.73% | -3.00% | -73.28% | +314.63% | -1.17% | +11.03% | +24668.84% | -99.63% | +22.07% | -6.02% | -132.81% | -491.33% | +3.59% | +28.26% | -126.27% | -560.06% | -10.14% | +49.73% | -140.78% | -406.89% | +85.54% | +10.46% | -56.37% | +225.63% | +42.57% | +18.12% | -99.97% | +436196.91% | +98.17% | -33.03% | n/a |